Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Idelalisib
Idelalisib
870281-82-6
|
415.156
|
3.62
Idelalisib is an antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma, and relapsed small lymphocytic lymphoma. Idelalisib specifically inhibits phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (P110δ).
CAL-101 | GS-1101 | idelalisib | zydelig
Idelalisib is an antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma, and relapsed small lymphocytic lymphoma. Idelalisib specifically inhibits phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (P110δ).
CAL-101 | GS-1101 | idelalisib | zydelig
$150/5 mg
(EBC)
1
CAS:870281-82-6
0
We provide 0 compound for Idelalisib